[ad_1] A Google parent-owned startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end, marking a significant milestone in pharmaceutical development as major tech companies increasingly invest in AI-powered healthcare solutions. What Happened: Isomorphic Labs, an Alphabet Inc. GOOGL subsidiary, is targeting major disease areas including oncology, cardiovascular conditions, and […]